Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

1998-08-13

Original market date: See footnote 1

1986-12-31

Product name:

FEIBA VH IMMUNO ANTI INHIBITOR

DIN:

00609137 Electronic product monograph is not available

Company:

OSTERREICHISCHES INSTITUT FUR HAEMODERIVATE GES M.B.H.
67 Industriestrasse
Vienna
--
Austria 1221

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

5

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

20:28.16 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B02BD03 FACTOR VIII INHIBITOR BYPASSING ACTIVITY

Active ingredient group (AIG) number:See footnote5

0516347001

List of active ingredient(s)
Active ingredient(s) Strength
ANTIHEMOPHILIC FACTOR (HUMAN) 4 UNIT / ML
COAGULATION FACTOR II (HUMAN) null NIL / ML
COAGULATION FACTOR VII (HUMAN) null NIL / ML
COAGULATION FACTOR X (HUMAN) null NIL / ML
FACTOR IX COMPLEX HUMAN null NIL / ML
Version 4.0.2
Date modified: